#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aplastic anaemia Osteosarcoma metastatic Oropharyngeal squamous cell carcinoma Usher's syndrome Waldenstrom's macroglobulinaemia refractory Dedifferentiated liposarcoma Langerhans' cell histiocytosis Eosinophilic granulomatosis with polyangiitis Pleomorphic liposarcoma Systemic sclerosis pulmonary Pulmonary arterial hypertension Breast angiosarcoma Lymphangiosarcoma Congenital generalised lipodystrophy Cervix carcinoma More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Basic Information Mantle cell lymphoma stage II Kearns-Sayre syndrome Pemphigoid – Basic Information Mucopolysaccharidosis – Basic Information Breast angiosarcoma metastatic – Life with Disease Atypical haemolytic uraemic syndrome – Basic Information Methylmalonic acidaemia – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease Mucopolysaccharidosis III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SPY002 Roginolisib Xevinapant Other Blood Products BENZYLPENICILLIN POTASSIUM Ixekizumab Gen1046 Pertuzumab Pitavastatin Calcium Dazukibart Sodium Acetate Trihydrate Ondansetron Azenosertib Tiratricol Paracetamol Docetaxel HUMAN COAGULATION FACTOR XIII Sodium Iodide (131I) Osilodrostat Magnesium Oxide, Light More therapies…

    Learn about Your Condition

    Pancoast's tumour Cleft lip and palate Hyperphagia Vulvovaginal pain Noninfective chorioretinitis Juvenile idiopathic arthritis Cervix carcinoma stage I Retinal vein occlusion Chondrosarcoma Adenocarcinoma gastric Bipolar I disorder Glioma Tissue anoxia Herpes simplex Incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Spitalul Clinic De Psihiatrie Si Neurologie Brasov

Spitalul Clinic De Psihiatrie Si Neurologie Brasov

Ssbhrh Prwiwxxoq 7dpq Bptwdbx 5bmhdis Rivwgsq

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

    Recruiting

    3 1 1
    Investigated Drugs:
    • Aripiprazole
    • Fluoxetine Hydrochloride
    • Risperidone
    Bulgaria Romania

  • Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Brexpiprazole
    • Brexpiprazole Fumarate
    Romania

  • A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

    Recruiting

    3 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Denmark France Italy Poland Romania

  • Long-Term Safety Study of Direclidine in Adults with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer’s disease patients

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Croatia Greece Portugal Romania Spain

  • Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Finland France Germany Greece Italy The Netherlands +4

  • Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer’s disease patients: Long-term safety evaluation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Croatia Czechia France Greece Hungary +5

  • Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

    Recruiting

    3 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Croatia Romania Slovakia Spain Sweden
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!